Cargando…
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
AIMS: Endothelial activation, macrophage infiltration, and foam cell formation are pivotal steps in atherogenesis. Our aim in this study was to analyse the role of SIRT1, a class III deacetylase with important metabolic functions, in plaque macrophages and atherogenesis. METHODS AND RESULTS: Using p...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938465/ https://www.ncbi.nlm.nih.gov/pubmed/20418343 http://dx.doi.org/10.1093/eurheartj/ehq107 |
_version_ | 1782186624354877440 |
---|---|
author | Stein, Sokrates Lohmann, Christine Schäfer, Nicola Hofmann, Janin Rohrer, Lucia Besler, Christian Rothgiesser, Karin M. Becher, Burkhard Hottiger, Michael O. Borén, Jan McBurney, Michael W. Landmesser, Ulf Lüscher, Thomas F. Matter, Christian M. |
author_facet | Stein, Sokrates Lohmann, Christine Schäfer, Nicola Hofmann, Janin Rohrer, Lucia Besler, Christian Rothgiesser, Karin M. Becher, Burkhard Hottiger, Michael O. Borén, Jan McBurney, Michael W. Landmesser, Ulf Lüscher, Thomas F. Matter, Christian M. |
author_sort | Stein, Sokrates |
collection | PubMed |
description | AIMS: Endothelial activation, macrophage infiltration, and foam cell formation are pivotal steps in atherogenesis. Our aim in this study was to analyse the role of SIRT1, a class III deacetylase with important metabolic functions, in plaque macrophages and atherogenesis. METHODS AND RESULTS: Using partial SIRT1 deletion in atherosclerotic mice, we demonstrate that SIRT1 protects against atherosclerosis by reducing macrophage foam cell formation. Peritoneal macrophages from heterozygous SIRT1 mice accumulate more oxidized low-density lipoprotein (oxLDL), thereby promoting foam cell formation. Bone marrow-restricted SIRT1 deletion confirmed that SIRT1 function in macrophages is sufficient to decrease atherogenesis. Moreover, we show that SIRT1 reduces the uptake of oxLDL by diminishing the expression of lectin-like oxLDL receptor-1 (Lox-1) via suppression of the NF-κB signalling pathway. CONCLUSION: Our findings demonstrate protective effects of SIRT1 in atherogenesis and suggest pharmacological SIRT1 activation as a novel anti-atherosclerotic strategy by reducing macrophage foam cell formation. |
format | Text |
id | pubmed-2938465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29384652010-09-15 SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis Stein, Sokrates Lohmann, Christine Schäfer, Nicola Hofmann, Janin Rohrer, Lucia Besler, Christian Rothgiesser, Karin M. Becher, Burkhard Hottiger, Michael O. Borén, Jan McBurney, Michael W. Landmesser, Ulf Lüscher, Thomas F. Matter, Christian M. Eur Heart J Basic Science AIMS: Endothelial activation, macrophage infiltration, and foam cell formation are pivotal steps in atherogenesis. Our aim in this study was to analyse the role of SIRT1, a class III deacetylase with important metabolic functions, in plaque macrophages and atherogenesis. METHODS AND RESULTS: Using partial SIRT1 deletion in atherosclerotic mice, we demonstrate that SIRT1 protects against atherosclerosis by reducing macrophage foam cell formation. Peritoneal macrophages from heterozygous SIRT1 mice accumulate more oxidized low-density lipoprotein (oxLDL), thereby promoting foam cell formation. Bone marrow-restricted SIRT1 deletion confirmed that SIRT1 function in macrophages is sufficient to decrease atherogenesis. Moreover, we show that SIRT1 reduces the uptake of oxLDL by diminishing the expression of lectin-like oxLDL receptor-1 (Lox-1) via suppression of the NF-κB signalling pathway. CONCLUSION: Our findings demonstrate protective effects of SIRT1 in atherogenesis and suggest pharmacological SIRT1 activation as a novel anti-atherosclerotic strategy by reducing macrophage foam cell formation. Oxford University Press 2010-09 2010-04-23 /pmc/articles/PMC2938465/ /pubmed/20418343 http://dx.doi.org/10.1093/eurheartj/ehq107 Text en Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/2.0/uk/ The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org |
spellingShingle | Basic Science Stein, Sokrates Lohmann, Christine Schäfer, Nicola Hofmann, Janin Rohrer, Lucia Besler, Christian Rothgiesser, Karin M. Becher, Burkhard Hottiger, Michael O. Borén, Jan McBurney, Michael W. Landmesser, Ulf Lüscher, Thomas F. Matter, Christian M. SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis |
title | SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis |
title_full | SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis |
title_fullStr | SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis |
title_full_unstemmed | SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis |
title_short | SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis |
title_sort | sirt1 decreases lox-1-mediated foam cell formation in atherogenesis |
topic | Basic Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938465/ https://www.ncbi.nlm.nih.gov/pubmed/20418343 http://dx.doi.org/10.1093/eurheartj/ehq107 |
work_keys_str_mv | AT steinsokrates sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT lohmannchristine sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT schafernicola sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT hofmannjanin sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT rohrerlucia sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT beslerchristian sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT rothgiesserkarinm sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT becherburkhard sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT hottigermichaelo sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT borenjan sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT mcburneymichaelw sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT landmesserulf sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT luscherthomasf sirt1decreaseslox1mediatedfoamcellformationinatherogenesis AT matterchristianm sirt1decreaseslox1mediatedfoamcellformationinatherogenesis |